1.
McGonagle D, Gibbon W, Emery P (1998) Classification of inflammatory arthritis by enthesitis. Lancet 352(9134):1137–1140
CrossRefPubMed
2.
Jacques P, Lambrecht S, Verheugen E, Pauwels E, Kollias G, Armaka M et al (2014) Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis 73(2):437–445
CrossRefPubMed
3.
Carette S, Graham D, Little H, Rubenstein J, Rosen P (1983) The natural disease course of ankylosing spondylitis. Arthritis Rheum 26(2):186–190
CrossRefPubMed
4.
Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH et al (2013) The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 65(10):2645–2654
PubMedCentralPubMed
5.
Baraliakos X, Listing J, von der Recke A, Braun J (2009) The natural course of radiographic progression in ankylosing spondylitis–evidence for major individual variations in a large proportion of patients. J Rheumatol 36(5):997–1002
CrossRefPubMed
6.
Ramiro S, Stolwijk C, van Tubergen A, van der Heijde D, Dougados M, van den Bosch F, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Annals of the Rheumatic Diseases 2013 Aug 16.
7.
van Tubergen A, Coenen J, Landewe R, Spoorenberg A, Chorus A, Boonen A et al (2002) Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Rheum 47(1):8–16
CrossRefPubMed
8.
Rezvani A, Bodur H, Ataman S, Kaya T, Bugdayci DS, Demir SE et al (2014) Correlations among enthesitis, clinical, radiographic and quality of life parameters in patients with ankylosing spondylitis. Modern Rheumatol / Jap Rheumat Assoc 24(4):651–656
CrossRef
9.
Fabreguet I, Koumakis E, Burki V, Durnez A, Elhai M, Meyer M (2012) Assessment of work instability in spondyloarthritis: a cross-sectional study using the ankylosing spondylitis work instability scale. Rheumatology (Oxford, England) 51(2):333–337
CrossRef
10.
Calvo-Gutierrez J, Garrido-Castro JL, Gil-Cabezas J, Gonzalez-Navas C, Ugalde PF, Carmona L et al (2015) Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation? Arthr Care Res 67(1):74–79
CrossRef
11.
Landewe R, Dougados M, Mielants H, van der Tempel H, van der Heijde D (2009) Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis 68(6):863–867
CrossRefPubMed
12.
Poddubnyy D, Haibel H, Listing J, Marker-Hermann E, Zeidler H, Braun J et al (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64(5):1388–1398
CrossRefPubMed
13.
Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F et al (2014) Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 7
14.
The Australo-Anglo-American Spondyloarthritis Consortium (TASC), the Wellcome Trust Case Control Consortium 2 (WTCCC2), The Australo-Anglo-American Spondyloarthritis Consortium (TASC), the Wellcome Trust Case Control Consortium 2 (WTCCC2), Evans DM, Spencer CC, Pointon JJ, Su Z (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43(8):761–767
CrossRef
15.
Australo-Anglo-American Spondyloarthritis Consortium (TASC), Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010 Feb;42(2):123–127
16.
Chen C, Zhang X, Wang Y (2012) ANTXR2 and IL-1R2 polymorphisms are not associated with ankylosing spondylitis in Chinese Han population. Rheumatol Int 32(1):15–19
CrossRefPubMed
17.
Guo C, Xia Y, Yang Q, Qiu R, Zhao H, Liu Q (2012) Association of the ANTXR2 gene polymorphism and ankylosing spondylitis in Chinese Han. Scand J Rheumatol 41(1):29–32
CrossRefPubMed
18.
Xia Y, Chen K, Zhang MH, Wang LC, Ma CY, Lin YL et al (2015) MicroRNA-124 involves in ankylosing spondylitis by targeting ANTXR2. Modern Rheumatol / Jap Rheumat Assoc 4:1–24
19.
Nollet M, Santucci-Darmanin S, Breuil V, Al-Sahlanee R, Cros C, Topi M et al (2014) Autophagy in osteoblasts is involved in mineralization and bone homeostasis. Autophagy 10(11):1965–1977
CrossRefPubMed
20.
Alander CB, Raisz LG (2006) Effects of selective prostaglandins E2 receptor agonists on cultured calvarial murine osteoblastic cells. Prostagland lipid Mediat 81(3–4):178–183
CrossRef
21.
Mano M, Arakawa T, Mano H, Nakagawa M, Kaneda T, Kaneko H et al (2000) Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor. Calcif Tissue Int 67(1):85–92
CrossRefPubMed
22.
Namikawa T, Terai H, Hoshino M, Kato M, Toyoda H, Yano K et al (2007) Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model. Spine 32(21):2294–2299
CrossRefPubMed
23.
Simon AM, Manigrasso MB, O’Connor JP (2002) Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Mineral Res : Off J Am Soc Bone Mineral Res 17(6):963–976
CrossRef
24.
Xie C, Liang B, Xue M, Lin AS, Loiselle A, Schwarz EM et al (2009) Rescue of impaired fracture healing in COX-2−/− mice via activation of prostaglandin E2 receptor subtype 4. Am J Pathol 175(2):772–785
CrossRefPubMedCentralPubMed
25.
Haroon N, Kim TH, Inman RD. NSAIDs and radiographic progression in ankylosing spondylitis Bagging big game with small arms? Annals of the Rheumatic Diseases 2012 Aug 3
26.
Cortes A, Maksymowych WP, Wordsworth BP, Inman RD, Danoy P, Rahman P, et al. Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis. Annals of the Rheumatic Diseases 2014 Apr 10
27.
Qian BP, Wang XQ, Qiu Y, Jiang J, Ji ML, Feng F (2014) Association of receptor activator of nuclear factor-kappaB ligand (RANKL) gene polymorphisms with the susceptibility to ankylosing spondylitis: a case–control study. J Orthop Sci : Off J Jap Orthop Assoc 19(2):207–212
CrossRef
28.
Klingberg E, Nurkkala M, Carlsten H, Forsblad-d’Elia H (2014) Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis. J Rheumatol 41(7):1349–1356
CrossRefPubMed
29.
Lin Z, Bei JX, Shen M, Li Q, Liao Z, Zhang Y et al (2011) A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet 44(1):73–77
CrossRefPubMed
30.
Urano T, Narusawa K, Shiraki M, Sasaki N, Hosoi T, Ouchi Y et al (2011) Single-nucleotide polymorphism in the hyaluronan and proteoglycan link protein 1 (HAPLN1) gene is associated with spinal osteophyte formation and disc degeneration in Japanese women. European Spine J : Off Public Europ Spine Soc, Europ Spinal Deform Soc, Europ Sec Cerv Spine Res Soc 20(4):572–577
CrossRef
31.
Wang Z, Kundu RK, Longaker MT, Quertermous T, Yang GP (2012) The angiogenic factor Del1 prevents apoptosis of endothelial cells through integrin binding. Surgery 151(2):296–305
CrossRefPubMed
32.
Takai A, Inomata H, Arakawa A, Yakura R, Matsuo-Takasaki M, Sasai Y (2010) Anterior neural development requires Del1, a matrix-associated protein that attenuates canonical Wnt signaling via the Ror2 pathway. Development (Cambridge, England) 137(19):3293–3302
CrossRef
33.
Haroon N, Maksymowych W, Rahman P, Tsui F, O’Shea F, Inman R. Radiographic severity in ankylosing spondylitis is associated with polymorphism in large multifunctional peptidase 2 (LMP2) in the SPARCC cohort. Arthritis and Rheumatism 2011 Oct 27
34.
Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D et al (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13(2):156–163
CrossRefPubMed
35.
Uderhardt S, Diarra D, Katzenbeisser J, David JP, Zwerina J, Richards W et al (2010) Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. Ann Rheum Dis 69(3):592–597
CrossRefPubMed
36.
Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M et al (2010) Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 62(1):150–158
CrossRefPubMed
37.
Heiland GR, Appel H, Poddubnyy D, Zwerina J, Hueber A, Haibel H et al (2012) High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis 71(4):572–574
CrossRefPubMed
38.
Chen MH, Chen HA, Chen WS, Chen MH, Tsai CY, Chou CT (2015) Upregulation of BMP-2 expression in peripheral-blood mononuclear cells by proinflammatory cytokines and radiographic progression in ankylosing spondylitis. Modern Rheumatol / Jap Rheumat Assoc 2:1–22
39.
Chen HA, Chen CH, Lin YJ, Chen PC, Chen WS, Lu CL et al (2010) Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol 37(10):2126–2132
CrossRefPubMed
40.
Lories RJ, Derese I, Luyten FP (2005) Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 115(6):1571–1579
CrossRefPubMedCentralPubMed
41.
Kiltz U, van der Heijde D, Mielants H, Feldtkeller E, Braun J, PARE/EULAR patient initiative group (2009) ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version. Ann Rheum Dis 68(9):1381–1386
CrossRefPubMed
42.
Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L et al (2015) 2014 update of the Canadian rheumatology association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. part II: specific management recommendations. J Rheumatol 42(4):665–681
CrossRefPubMed
43.
Wanders A, Heijde D, Landewe R, Behier JM, Calin A, Olivieri I et al (2005) Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 52(6):1756–1765
CrossRefPubMed
44.
Kroon F, Landewe R, Dougados M, van der Heijde D (2012) Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 5
45.
Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Marker-Hermann E, Zeidler H et al (2012) Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 29
46.
Spiro AS, Beil FT, Baranowsky A, Barvencik F, Schilling AF, Nguyen K et al (2010) BMP-7-induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6-mice. J Orthop Res : Off Public Orthop Res Soc 28(6):785–791
47.
Li Q, Zhang Z, Cai Z (2011) High-dose ketorolac affects adult spinal fusion: a meta-analysis of the effect of perioperative nonsteroidal anti-inflammatory drugs on spinal fusion. Spine 36(7):E461–E468
CrossRefPubMed
48.
Herbenick MA, Sprott D, Stills H, Lawless M (2008) Effects of a cyclooxygenase 2 inhibitor on fracture healing in a rat model. Am J Orthop (Belle Mead, NJ) 37(7):E133–E137
49.
Reuben SS, Ablett D, Kaye R (2005) High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion. Canadian journal of anaesthesia =. J Can d’anesthesie 52(5):506–512
CrossRef
50.
Romano CL, Duci D, Romano D, Mazza M, Meani E (2004) Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J Arthroplast 19(1):14–18
CrossRef
51.
Welting TJ, Caron MM, Emans PJ, Janssen MP, Sanen K, Coolsen MM et al (2011) Inhibition of cyclooxygenase-2 impacts chondrocyte hypertrophic differentiation during endochondral ossification. Europ Cells Mat 22:420–436, discussion 436–7
52.
Baraliakos X, Listing J, Rudwaleit M, Brandt J, Sieper J, Braun J (2005) Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab. Ann Rheum Dis 64(10):1462–1466
CrossRefPubMedCentralPubMed
53.
Baraliakos X, Listing J, Brandt J, Haibel H, Rudwaleit M, Sieper J (2007) Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab. Rheumatology (Oxford, England) 46(9):1450–1453
CrossRef
54.
van der Heijde D, Landewe R, Baraliakos X, Houben H, van Tubergen A, Williamson P et al (2008) Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 58(10):3063–3070
CrossRefPubMed
55.
van der Heijde D, Salonen D, Weissman BN, Landewe R, Maksymowych WP, Kupper H et al (2009) Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arth Res Therap 11(4):R127
CrossRef
56.
Baraliakos X, Haibel H, Listing J, Sieper J, Braun J (2013) Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis. Ann Rheum Dis 27